ArticleJHEP reports : innovation in hepatology2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
Max Seidensticker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it